https://www.fda.gov/drugs/drug-trials-snapshots/drug-trials-snapshot-vanrafia
Drug Trials Snapshot: VANRAFIA | FDA
VANRAFIA is an endothelin type A receptor antagonist that is indicated to reduce proteinuria in adults with primary immunoglobulin A (IgA) nephropathy at risk...
drug trialssnapshotfda